Compute for Personalized Medicine: White Paper
It’s Changing Faster than Moore’s Law, but Is U.S. Policy Keeping Pace?
In 1990, the U.S. launched an audacious scientific endeavor with the potential to change the practice of medicine when the National Institutes of Health and the Department of Energy joined with the international community in a quest to sequence all 3 billion letters, or base pairs, in the human genome, which is the complete set of DNA in the human body. This concerted, public effort was the Human Genome Project (HGP). By 2000, scientists broke the code and paved the way for an explosion of investment in genetic and genomic testing, generating 116,000 U.S. jobs and USD 16.5 billion in national economic output. These developments are being repeated in Oslo, Beijing, and around the world.
Stemming from the human genome sequencing is a new field referred to as personalized medicine, where providers and patients use diagnostic tools to identify specific molecular characteristics to help assess which medical treatments and procedures are best for the patient.
Read the full Compute for Personalized Medicine White Paper.